TEVIWE: Drawing a New Global Blueprint for Healthy Aging through Technological Innovation
Boston, Massachusetts, April 15, 2025 (GLOBE NEWSWIRE) -- High-fat diets, chronic sleep…
GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders
GENFIT completes a royalty financing of up to €185 million with HCRx…
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ --…
Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
All resolutions approved by bondholders Closing of Royalty Financing and receipt of…
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx)…
The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio REN Wearable for Acute and Preventive Treatment of Migraine
BRIDGEWATER, N.J. and NETANYA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Theranica,…
GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to…
Bioxytrans Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs
BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT)…